Shares of Organogenesis Holdings Inc. (ORGO) are down 29% from their 52-week of $4.57, recorded last November, and trade around $3. This regenerative medicine company is focused on the development and sale of products for the advanced wound care, and surgical and sports medicine markets.The company provided its outlook for the full year 2024 while reporting Q3 results recently.For the full-year of...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.